The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma
Osteosarcoma (OS) is a rare but aggressive malignancy. Despite previous reports, molecular characterization of this disease is not well understood, and little is known regarding OS in Chinese patients. Herein, we analyzed the genomic signatures of 73 Chinese OS cases. TP53, NCOR1, LRP1B, ATRX, RB1,...
Main Authors: | Weifeng Liu, Huanqing Cheng, Zhen Huang, Yaping Li, Yanrui Zhang, Yongkun Yang, Tao Jin, Yang Sun, Zhiping Deng, Qing Zhang, Feng Lou, Shanbo Cao, Huina Wang, Xiaohui Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-04-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13526 |
Similar Items
-
Radiological Assessment and Outcome of Local Disease Progression after Neoadjuvant Chemotherapy in Children and Adolescents with Localized Osteosarcoma
by: Adriana Fonseca, et al.
Published: (2020-12-01) -
Imaging evaluation of blood supply changes after chemotherapy of osteosarcoma and its correlation with tumor necrosis rate
by: Yongkun Yang, et al.
Published: (2023-08-01) -
Autophagy and its role in osteosarcoma
by: Biao Ning, et al.
Published: (2023-03-01) -
Primary hepatic carcinosarcoma with osteosarcoma components: A case report and literature review
by: Xiao-Min Deng, et al.
Published: (2023-12-01) -
Cellular and Genetic Background of Osteosarcoma
by: Inga Urlić, et al.
Published: (2023-05-01)